Stem Cell Treatment Market Analysis

  • Report ID: 1329
  • Published Date: Oct 10, 2024
  • Report Format: PDF, PPT

Stem Cell Treatment Market Analysis

Treatment Type (Allogeneic, Autologous, Syngeneic)

The global stem cell treatment market is segmented and analyzed for demand and supply by treatment type into allogeneic, autologous and syngeneic. Out of these, the allogeneic segment is estimated to gain the largest market share of about 43% in the year 2037. The allogeneic segment is gaining popularity owing to its ability to provide long-term benefits for patients, cost effectiveness, and the potential for personalized treatments. Additionally, advancements in stem cell technology and the increasing demand for stem cell therapies are further driving the growth of the allogeneic segment. Moreover, the increasing incidence of blood cancer and genetic disorders are also expected to fuel the segment growth. It is estimated that someone in the US die of a blood cancer every nine minutes. An estimated 57,750 people died from leukemia, lymphoma, and myeloma in the US in 2021. The number of Australians suffering from blood cancer or blood disorders today is around 135,000. Allogeneic stem cell transplant involves harvesting healthy stem cells from a donor and transplanting them into the patient. The healthy stem cells can then proliferate and replace the cancerous cells, allowing the patient to recover from the disease.

Application (Regenerative Medicine, Drug Discovery, Development)

The global stem cell treatment market is segmented and analyzed for demand and supply by application to regenerative medicine and drug discovery and development. Out of these, the regenerative medicine segment is estimated to gain significant market share of about 57% in the year 2037. The growth of the segment can be attributed to the rising awareness and acceptance of regenerative medicine as regenerative medicine has the potential to revolutionize the healthcare industry by providing treatments for previously untreatable conditions with better outcomes. According to current estimates, regenerative medicine is estimated to potentially have a significant impact on a staggering one out of three Americans. Additionally, advancements in technology have enabled the development of more advanced regenerative medicine treatments that are more effective, faster, and safer. Furthermore, the increasing government funding for regenerative medicine research is expected to lead to further advancements in the field.

Our in-depth analysis of the global market includes the following segments:

                By Stem Cell Type

  • Embryonic cells
  • Somatic cells
  • Pluripotent cells

               By Treatment Type

 

  • Allogeneic
  • Autologous
  • Syngeneic

               By Application

  • Regenerative Medicine
  • Drug Discovery and Development

              By Stem Cell Technology

  • Cell Acquisition
    • Bone Marrow Harvest
    • Umbilical Blood Cord
    • Apheresis
  • Cell Production
    • Therapeutic Cloning
    • In-vitro Fertilization
    • Cell Culture
    • Isolation
  • Cryopreservation
  • Expansion and Subculture

             By End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Clinics
  • Others
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 1329
  • Published Date: Oct 10, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of stem cell treatment is evaluated at USD 382.8 million.

The stem cell treatment market size was over USD 343.26 million in 2024 and is projected to exceed USD 1.97 billion by the end of 2037, growing at over 14.3% CAGR during the forecast period i.e., between 2025-2037. The increasing prevalence of chronic and genetic diseases, along with the increasing awareness about the benefits of stem cell treatments will boost the market growth.

North America is poised to be the largest with a share of about 39% by 2037, propelled by increasing awareness about the potential of stem cell treatments, rising prevalence of chronic diseases such as diabetes, technological advancements in the field, and presence of favorable reimbursement policies in the region.

The major players in the market include Stemedica Cell Technologies, Inc., Pluristem Therapeutics Inc., Thermo Fisher Scientific, Becton, Dickinson and Company, Advanced Cell Technology Inc., Cellular Engineering Technologies Inc., CellGenix GmbH, PromoCell GmbH, Kite Pharma, Genea Biocells.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample